首页> 外文期刊>Journal of Clinical Microbiology >PCR Assays for Identification of Coccidioides posadasii Based on the Nucleotide Sequence of the Antigen 2/Proline-Rich Antigen
【24h】

PCR Assays for Identification of Coccidioides posadasii Based on the Nucleotide Sequence of the Antigen 2/Proline-Rich Antigen

机译:基于抗原2 /富含脯氨酸的抗原的核苷酸序列鉴定球孢子虫的PCR分析

获取原文
       

摘要

A conventional nested PCR and a real-time LightCycler PCR assay for detection of Coccidioides posadasii DNA were designed and tested in 120 clinical strains. These had been isolated from 114 patients within 10 years in Monterrey, Nuevo Leon, Mexico, known to be endemic for coccidioidomycosis. The gene encoding the specific antigen 2/proline-rich antigen (Ag2/PRA) was used as a target. All strains were correctly identified, whereas DNA from related members of the family Onygenaceae remained negative. Melting curve analysis by LightCycler and sequencing of the 526-bp product of the first PCR demonstrated either 100% identity to the GenBank sequence of the Silveira strain, now known to be C. posadasii (accession number AF013256), or a single silent mutation at position 1228. Length determination of two microsatellite-containing loci (GAC and 621) identified all 120 isolates as C. posadasii. Specific DNA was amplified by conventional nested PCR from three microscopically spherule-positive paraffin-embedded tissue samples, whereas 20 human tissue samples positive for other dimorphic fungi remained negative. Additionally, the safety of each step of a modified commercially available DNA extraction procedure was evaluated by using 10 strains. At least three steps of the protocol were demonstrated to sufficiently kill arthroconidia. This safe procedure is applicable to cultures and to clinical specimens.
机译:设计了常规巢式PCR和实时LightCycler PCR检测法,以检测120株临床上的Coccidioides posadasii DNA。这些是在10年内从墨西哥新莱昂州蒙特雷的114名患者中分离出来的,该患者因球孢子菌病而流行。将编码特异性抗原2 /富含脯氨酸的抗原(Ag2 / PRA)的基因用作靶标。正确鉴定了所有菌株,而 On科家族相关成员的DNA仍然阴性。通过LightCycler进行的熔解曲线分析和第一个PCR的526-bp产物的测序表明与Silveira菌株的GenBank序列具有100%的同一性,该菌株现在称为C。 posadasii (登录号AF013256)或位置1228处的单个沉默突变。两个含微卫星基因座(GAC和621)的长度测定确定所有120个分离株为 C。 posadasii 。通过常规的巢式PCR,从三个显微球体阳性石蜡包埋的组织样本中扩增出特定的DNA,而其他双态真菌阳性的20个人类组织样本仍为阴性。此外,使用10株菌株评估了改良的市售DNA提取程序每个步骤的安全性。协议中的至少三个步骤被证明足以杀死关节炎。此安全程序适用于培养和临床标本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号